We are running low on funds, we were paying something like $20,000 per month and now you, a non holder, have the nerve to keep sticking the boot. You piece of sh$t
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
